- Report
- March 2024
- 194 Pages
Global
From €3241EUR$3,374USD£2,766GBP
€3601EUR$3,749USD£3,074GBP
- Report
- February 2024
- 120 Pages
Global
From €4106EUR$4,275USD£3,505GBP
€4562EUR$4,750USD£3,895GBP
- Report
- February 2021
- 420 Pages
United States
From €2305EUR$2,400USD£1,968GBP
- Report
- September 2019
- 40 Pages
Saudi Arabia
From €2492EUR$2,595USD£2,128GBP
- Report
- September 2019
- 40 Pages
United States
From €2492EUR$2,595USD£2,128GBP
- Report
- September 2019
- 40 Pages
Russia
From €2492EUR$2,595USD£2,128GBP
- Report
- September 2019
- 40 Pages
Ireland
From €2492EUR$2,595USD£2,128GBP
- Report
- September 2019
- 40 Pages
Germany
From €2492EUR$2,595USD£2,128GBP
- Report
- September 2019
- 40 Pages
France
From €2492EUR$2,595USD£2,128GBP
- Report
- March 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,173GBP
- Report
- March 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,173GBP
- Report
- March 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,173GBP
- Report
- March 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,173GBP
Desipramine is a tricyclic antidepressant used to treat depression and other mental health conditions. It is also used to treat gastrointestinal disorders such as irritable bowel syndrome, functional dyspepsia, and gastroesophageal reflux disease. Desipramine is a potent inhibitor of the reuptake of norepinephrine, a neurotransmitter involved in the regulation of gastrointestinal motility. It is thought to reduce symptoms of gastrointestinal disorders by increasing the availability of norepinephrine in the gut.
Desipramine is available in both generic and brand-name formulations. It is available in tablet, capsule, and liquid forms. It is typically taken orally, but can also be administered intravenously.
Desipramine is generally well-tolerated, but can cause side effects such as dry mouth, constipation, and drowsiness. It is important to discuss any potential side effects with a healthcare provider before taking desipramine.
Companies in the desipramine market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more